Literature DB >> 20591294

Endovascular treatment of B-AVM.

K G Terbrugge1.   

Abstract

Year:  2004        PMID： 20591294      PMCID： PMC3556656          DOI： 10.1177/15910199030090S221

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN： 1591-0199            Impact factor:   1.610


× No keyword cloud information.
  6 in total

1.  The endovascular treatment of brain arteriovenous malformations.

Authors:  A Valavanis; M G Yaşargil
Journal:  Adv Tech Stand Neurosurg       Date:  1998

2.  Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM.

Authors:  H J Meisel; U Mansmann; H Alvarez; G Rodesch; M Brock; P Lasjaunias
Journal:  Acta Neurochir (Wien)       Date:  2002-09       Impact factor: 2.216

3.  Embolisation of Small (< 3 cm) Brain Arteriovenous Malformations. Correlation of Angiographic Results to a Proposed Angioarchitecture Grading System.

Authors:  R Willinsky; M Goyal; K Terbrugge; W Montanera; M C Wallace; M Tymianski
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

4.  Palliative embolisation of brain arteriovenous malformations presenting with progressive neurological deficit.

Authors:  M Al-Yamany; K G Terbrugge; R Willinsky; W Montanera; M Tymianski; M C Wallace
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

5.  Microsurgical results for small arteriovenous malformations accessible for radiosurgical or embolization treatment.

Authors:  C Schaller; J Schramm
Journal:  Neurosurgery       Date:  1997-04       Impact factor: 4.654

6.  Factors associated with successful arteriovenous malformation radiosurgery.

Authors:  B E Pollock; J C Flickinger; L D Lunsford; A Maitz; D Kondziolka
Journal:  Neurosurgery       Date:  1998-06       Impact factor: 4.654
  6 in total
  1 in total

1.  Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects.

Authors:  W Weber; B Kis; R Siekmann; D Kuehne
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.